Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Work Schedule Tolerance | 56 | 2023 | 552 | 10.360 |
Why?
|
Melatonin | 42 | 2024 | 669 | 7.540 |
Why?
|
Nurses | 39 | 2023 | 2477 | 5.410 |
Why?
|
Circadian Rhythm | 46 | 2024 | 2569 | 4.930 |
Why?
|
Sleep | 31 | 2024 | 4764 | 2.290 |
Why?
|
Austria | 21 | 2024 | 206 | 2.040 |
Why?
|
Breast Neoplasms | 43 | 2023 | 20988 | 1.810 |
Why?
|
Occupational Diseases | 11 | 2023 | 1490 | 1.690 |
Why?
|
Photoperiod | 3 | 2023 | 139 | 1.440 |
Why?
|
Sleep Initiation and Maintenance Disorders | 8 | 2023 | 1081 | 1.430 |
Why?
|
Lighting | 8 | 2023 | 211 | 1.380 |
Why?
|
Light | 8 | 2015 | 1352 | 1.350 |
Why?
|
Depression | 13 | 2024 | 8132 | 1.300 |
Why?
|
Risk Factors | 115 | 2024 | 74128 | 1.240 |
Why?
|
Life Style | 16 | 2024 | 3907 | 1.130 |
Why?
|
Urinary Bladder Neoplasms | 6 | 2023 | 2223 | 1.120 |
Why?
|
Suicide | 5 | 2024 | 1601 | 1.110 |
Why?
|
Folic Acid | 6 | 2014 | 1323 | 1.060 |
Why?
|
Prospective Studies | 75 | 2024 | 54364 | 1.030 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 8 | 2015 | 416 | 1.020 |
Why?
|
Female | 202 | 2024 | 392203 | 1.010 |
Why?
|
Parkinson Disease | 14 | 2015 | 2878 | 1.010 |
Why?
|
Pineal Gland | 3 | 2023 | 158 | 0.970 |
Why?
|
Vitamin B 6 | 4 | 2014 | 234 | 0.950 |
Why?
|
Humans | 269 | 2024 | 760740 | 0.930 |
Why?
|
Pets | 1 | 2024 | 46 | 0.920 |
Why?
|
Colorectal Neoplasms | 20 | 2023 | 6927 | 0.910 |
Why?
|
Adult | 133 | 2024 | 220995 | 0.890 |
Why?
|
Menopause | 5 | 2020 | 1645 | 0.890 |
Why?
|
Mothers | 6 | 2022 | 2194 | 0.890 |
Why?
|
Occupational Exposure | 10 | 2023 | 1813 | 0.890 |
Why?
|
Chronobiology Disorders | 4 | 2019 | 73 | 0.880 |
Why?
|
Reproductive History | 2 | 2020 | 210 | 0.870 |
Why?
|
Veterinarians | 1 | 2023 | 13 | 0.860 |
Why?
|
Maternal Nutritional Physiological Phenomena | 2 | 2024 | 389 | 0.860 |
Why?
|
Middle Aged | 142 | 2024 | 220603 | 0.840 |
Why?
|
European Union | 1 | 2023 | 157 | 0.840 |
Why?
|
Seasons | 4 | 2023 | 1518 | 0.790 |
Why?
|
Premenopause | 7 | 2013 | 1038 | 0.780 |
Why?
|
Occupational Health | 7 | 2016 | 806 | 0.770 |
Why?
|
Proportional Hazards Models | 26 | 2022 | 12448 | 0.770 |
Why?
|
Insulin-Like Growth Factor I | 8 | 2015 | 1932 | 0.760 |
Why?
|
Trust | 2 | 2023 | 529 | 0.760 |
Why?
|
Diet | 10 | 2024 | 8049 | 0.750 |
Why?
|
Hormones | 3 | 2020 | 869 | 0.740 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 2020 | 104 | 0.740 |
Why?
|
Hair Dyes | 1 | 2020 | 30 | 0.730 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2024 | 2518 | 0.720 |
Why?
|
Body Size | 3 | 2015 | 463 | 0.710 |
Why?
|
Physicians | 5 | 2024 | 4583 | 0.710 |
Why?
|
Pandemics | 8 | 2024 | 8652 | 0.710 |
Why?
|
Cardiovascular Diseases | 15 | 2024 | 15498 | 0.690 |
Why?
|
Odds Ratio | 26 | 2020 | 9644 | 0.690 |
Why?
|
Ownership | 1 | 2022 | 339 | 0.690 |
Why?
|
Time Factors | 32 | 2020 | 39908 | 0.680 |
Why?
|
Wakefulness | 4 | 2017 | 1264 | 0.680 |
Why?
|
Strigiformes | 1 | 2019 | 2 | 0.680 |
Why?
|
Passeriformes | 1 | 2019 | 3 | 0.680 |
Why?
|
Neoplasms | 22 | 2024 | 22131 | 0.660 |
Why?
|
Butyrates | 1 | 2019 | 169 | 0.640 |
Why?
|
Sleep Stages | 1 | 2023 | 695 | 0.630 |
Why?
|
Postmenopause | 8 | 2019 | 2511 | 0.630 |
Why?
|
Adult Children | 1 | 2019 | 103 | 0.620 |
Why?
|
Anxiety | 3 | 2024 | 4573 | 0.620 |
Why?
|
Cohort Studies | 46 | 2024 | 41464 | 0.620 |
Why?
|
Obesity | 15 | 2024 | 12934 | 0.610 |
Why?
|
Coronavirus | 1 | 2020 | 156 | 0.610 |
Why?
|
Long Interspersed Nucleotide Elements | 5 | 2012 | 330 | 0.600 |
Why?
|
Vitamin B 12 | 3 | 2014 | 524 | 0.590 |
Why?
|
Efficiency | 1 | 2021 | 476 | 0.590 |
Why?
|
Overweight | 4 | 2024 | 2417 | 0.580 |
Why?
|
Dietary Sucrose | 2 | 2012 | 243 | 0.580 |
Why?
|
Smoking | 10 | 2023 | 9054 | 0.570 |
Why?
|
Sleep Disorders, Circadian Rhythm | 4 | 2021 | 196 | 0.570 |
Why?
|
Cognition | 9 | 2023 | 6988 | 0.550 |
Why?
|
Carcinoma, Basal Cell | 3 | 2020 | 557 | 0.550 |
Why?
|
Receptor, Melatonin, MT1 | 1 | 2016 | 31 | 0.550 |
Why?
|
Uncertainty | 2 | 2021 | 752 | 0.540 |
Why?
|
Case-Control Studies | 28 | 2020 | 22153 | 0.530 |
Why?
|
Alcohol Drinking | 6 | 2018 | 4028 | 0.530 |
Why?
|
Insulin-Like Growth Factor II | 3 | 2014 | 268 | 0.530 |
Why?
|
Vitamin B Complex | 2 | 2008 | 299 | 0.520 |
Why?
|
Hypertension | 9 | 2023 | 8532 | 0.520 |
Why?
|
Aged | 85 | 2024 | 169092 | 0.520 |
Why?
|
Proton Pump Inhibitors | 2 | 2020 | 533 | 0.500 |
Why?
|
Body Mass Index | 27 | 2024 | 12942 | 0.500 |
Why?
|
Colonic Neoplasms | 5 | 2011 | 2533 | 0.500 |
Why?
|
Pregnancy | 16 | 2024 | 29869 | 0.500 |
Why?
|
Risk | 16 | 2023 | 9603 | 0.490 |
Why?
|
Vitamin D | 4 | 2016 | 3301 | 0.490 |
Why?
|
Sweetening Agents | 2 | 2019 | 290 | 0.480 |
Why?
|
Methionine | 3 | 2014 | 572 | 0.480 |
Why?
|
Birth Weight | 2 | 2024 | 2101 | 0.470 |
Why?
|
Growth Hormone | 2 | 2007 | 569 | 0.470 |
Why?
|
Communicable Disease Control | 2 | 2020 | 846 | 0.470 |
Why?
|
Feeding Behavior | 4 | 2023 | 3183 | 0.470 |
Why?
|
Incidence | 30 | 2024 | 21339 | 0.460 |
Why?
|
Cross-Sectional Studies | 27 | 2024 | 26065 | 0.450 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4021 | 0.450 |
Why?
|
Resilience, Psychological | 1 | 2021 | 787 | 0.450 |
Why?
|
United States | 41 | 2024 | 72292 | 0.440 |
Why?
|
Denmark | 11 | 2015 | 770 | 0.430 |
Why?
|
Stress, Psychological | 6 | 2019 | 4488 | 0.430 |
Why?
|
Male | 86 | 2024 | 360402 | 0.420 |
Why?
|
Skin Neoplasms | 3 | 2020 | 5811 | 0.420 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3088 | 0.410 |
Why?
|
Dermatitis, Atopic | 1 | 2020 | 731 | 0.410 |
Why?
|
Logistic Models | 17 | 2020 | 13248 | 0.410 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3209 | 0.410 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 8 | 2011 | 2270 | 0.400 |
Why?
|
Personnel Staffing and Scheduling | 3 | 2016 | 495 | 0.400 |
Why?
|
Age Factors | 17 | 2020 | 18381 | 0.400 |
Why?
|
Somatomedins | 3 | 2007 | 179 | 0.390 |
Why?
|
Adolescent Development | 1 | 2015 | 282 | 0.390 |
Why?
|
Disease | 1 | 2017 | 670 | 0.380 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 3 | 2007 | 127 | 0.380 |
Why?
|
Optical Devices | 1 | 2011 | 35 | 0.380 |
Why?
|
Research | 1 | 2020 | 1977 | 0.380 |
Why?
|
Disorders of Excessive Somnolence | 2 | 2022 | 277 | 0.380 |
Why?
|
Carbonated Beverages | 1 | 2012 | 210 | 0.380 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 786 | 0.380 |
Why?
|
Gout Suppressants | 1 | 2013 | 177 | 0.370 |
Why?
|
Hot Flashes | 1 | 2014 | 330 | 0.370 |
Why?
|
Cause of Death | 6 | 2024 | 3683 | 0.370 |
Why?
|
Influenza, Human | 1 | 2022 | 1521 | 0.360 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2024 | 12143 | 0.360 |
Why?
|
Ethanol | 2 | 2014 | 1320 | 0.360 |
Why?
|
Endometrial Neoplasms | 3 | 2008 | 1365 | 0.350 |
Why?
|
Cholecystectomy | 2 | 2003 | 406 | 0.350 |
Why?
|
CpG Islands | 3 | 2012 | 1192 | 0.350 |
Why?
|
Menstrual Cycle | 4 | 2019 | 539 | 0.350 |
Why?
|
Adenoma | 5 | 2017 | 2159 | 0.340 |
Why?
|
Energy Intake | 2 | 2014 | 2133 | 0.340 |
Why?
|
Aspartame | 2 | 2023 | 19 | 0.330 |
Why?
|
Multivariate Analysis | 13 | 2019 | 12043 | 0.320 |
Why?
|
Pancreatic Neoplasms | 6 | 2007 | 5369 | 0.320 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1462 | 0.320 |
Why?
|
DNA Methylation | 8 | 2014 | 4392 | 0.320 |
Why?
|
Antihypertensive Agents | 4 | 2022 | 2018 | 0.310 |
Why?
|
Physicians, Women | 2 | 2024 | 509 | 0.310 |
Why?
|
Risk Assessment | 25 | 2020 | 23974 | 0.310 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 3 | 2007 | 208 | 0.310 |
Why?
|
Diabetes Mellitus | 4 | 2023 | 5838 | 0.310 |
Why?
|
Young Adult | 18 | 2022 | 59191 | 0.300 |
Why?
|
Follow-Up Studies | 22 | 2024 | 39062 | 0.300 |
Why?
|
Work | 3 | 2015 | 195 | 0.300 |
Why?
|
Aging | 9 | 2021 | 8700 | 0.290 |
Why?
|
Occupations | 4 | 2024 | 516 | 0.290 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2016 | 487 | 0.290 |
Why?
|
Endometriosis | 2 | 2015 | 857 | 0.280 |
Why?
|
Sex Factors | 11 | 2024 | 10549 | 0.280 |
Why?
|
Epirubicin | 3 | 1995 | 81 | 0.280 |
Why?
|
Cognition Disorders | 4 | 2019 | 3979 | 0.270 |
Why?
|
Ovarian Neoplasms | 8 | 2020 | 4849 | 0.270 |
Why?
|
Human Development | 1 | 2007 | 123 | 0.270 |
Why?
|
Homocysteine | 2 | 2022 | 637 | 0.270 |
Why?
|
Kidney Calculi | 2 | 2021 | 463 | 0.270 |
Why?
|
Meat | 1 | 2009 | 584 | 0.270 |
Why?
|
Affect | 1 | 2014 | 1486 | 0.260 |
Why?
|
Free Radical Scavengers | 1 | 2007 | 211 | 0.260 |
Why?
|
Asthma | 2 | 2020 | 6234 | 0.260 |
Why?
|
Wrist Injuries | 1 | 2008 | 214 | 0.260 |
Why?
|
Genes, ras | 1 | 2008 | 654 | 0.260 |
Why?
|
Longitudinal Studies | 9 | 2023 | 14599 | 0.260 |
Why?
|
Gout | 1 | 2013 | 621 | 0.250 |
Why?
|
Complementary Therapies | 1 | 2009 | 486 | 0.250 |
Why?
|
Melanoma | 2 | 2016 | 5696 | 0.250 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2008 | 396 | 0.240 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2012 | 1372 | 0.240 |
Why?
|
Nursing | 1 | 2004 | 34 | 0.240 |
Why?
|
Workplace | 1 | 2011 | 863 | 0.240 |
Why?
|
Gonadal Steroid Hormones | 2 | 2006 | 702 | 0.240 |
Why?
|
Reproduction | 2 | 2019 | 646 | 0.240 |
Why?
|
Health Personnel | 3 | 2023 | 3333 | 0.240 |
Why?
|
Aircraft | 1 | 2005 | 130 | 0.230 |
Why?
|
Europe | 4 | 2024 | 3415 | 0.230 |
Why?
|
Leukemia | 1 | 2012 | 1520 | 0.230 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 4242 | 0.230 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1388 | 0.230 |
Why?
|
Multiple Sclerosis | 1 | 2019 | 3222 | 0.230 |
Why?
|
Epigenesis, Genetic | 3 | 2014 | 3794 | 0.230 |
Why?
|
Aged, 80 and over | 28 | 2020 | 58919 | 0.230 |
Why?
|
Cyclin D1 | 1 | 2006 | 451 | 0.230 |
Why?
|
Aspirin | 6 | 2011 | 3127 | 0.230 |
Why?
|
Pregnancy Proteins | 1 | 2005 | 222 | 0.220 |
Why?
|
Antioxidants | 1 | 2012 | 1669 | 0.220 |
Why?
|
Eugenol | 1 | 2023 | 10 | 0.220 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 3 | 2017 | 1133 | 0.220 |
Why?
|
Creatinine | 5 | 2020 | 1895 | 0.220 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1669 | 0.220 |
Why?
|
Estrone | 1 | 2004 | 234 | 0.220 |
Why?
|
Sunlight | 2 | 2023 | 337 | 0.210 |
Why?
|
Attitude to Health | 2 | 2009 | 2025 | 0.210 |
Why?
|
Quality of Life | 4 | 2023 | 13359 | 0.210 |
Why?
|
Delphi Technique | 2 | 2024 | 846 | 0.210 |
Why?
|
Estradiol | 4 | 2013 | 1937 | 0.210 |
Why?
|
Eczema | 2 | 2020 | 246 | 0.200 |
Why?
|
Sex Distribution | 2 | 2024 | 2278 | 0.200 |
Why?
|
Phosphatidylcholines | 1 | 2024 | 405 | 0.200 |
Why?
|
Testosterone | 1 | 2013 | 2472 | 0.200 |
Why?
|
Health Behavior | 3 | 2015 | 2643 | 0.200 |
Why?
|
Choline | 1 | 2024 | 515 | 0.200 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2011 | 2057 | 0.200 |
Why?
|
Menstruation Disturbances | 2 | 2015 | 143 | 0.200 |
Why?
|
Snoring | 3 | 2022 | 209 | 0.190 |
Why?
|
Finland | 1 | 2023 | 607 | 0.190 |
Why?
|
Mortality | 6 | 2024 | 2899 | 0.190 |
Why?
|
Biological Clocks | 1 | 2024 | 318 | 0.190 |
Why?
|
Object Attachment | 1 | 2024 | 326 | 0.190 |
Why?
|
Digestive System Neoplasms | 1 | 2021 | 83 | 0.190 |
Why?
|
Dentists | 1 | 2023 | 178 | 0.190 |
Why?
|
Inflammation | 2 | 2019 | 10759 | 0.190 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2022 | 323 | 0.190 |
Why?
|
Dehydroepiandrosterone | 2 | 2017 | 258 | 0.190 |
Why?
|
Government | 1 | 2022 | 160 | 0.180 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 361 | 0.180 |
Why?
|
Adolescent | 13 | 2022 | 88247 | 0.180 |
Why?
|
Nutrition Assessment | 1 | 2024 | 726 | 0.180 |
Why?
|
Fractures, Bone | 2 | 2014 | 2045 | 0.180 |
Why?
|
Urban Health | 1 | 2023 | 532 | 0.180 |
Why?
|
Pharmacists | 1 | 2023 | 259 | 0.180 |
Why?
|
Cholelithiasis | 1 | 2002 | 407 | 0.180 |
Why?
|
Waist-Hip Ratio | 2 | 2015 | 518 | 0.180 |
Why?
|
Mycotoxins | 1 | 2020 | 35 | 0.180 |
Why?
|
Vitamin A | 1 | 2003 | 612 | 0.180 |
Why?
|
Olfaction Disorders | 1 | 2023 | 224 | 0.180 |
Why?
|
Leishmaniasis, Visceral | 1 | 2021 | 99 | 0.180 |
Why?
|
Hydrocortisone | 2 | 2019 | 1819 | 0.170 |
Why?
|
Caffeine | 2 | 2015 | 699 | 0.170 |
Why?
|
Congresses as Topic | 2 | 2021 | 802 | 0.170 |
Why?
|
Infectious Disease Medicine | 1 | 2020 | 49 | 0.170 |
Why?
|
Beverages | 1 | 2005 | 821 | 0.170 |
Why?
|
Registries | 11 | 2022 | 8209 | 0.170 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2019 | 9277 | 0.170 |
Why?
|
Respiratory Tract Diseases | 2 | 2024 | 750 | 0.170 |
Why?
|
Knowledge | 1 | 2021 | 177 | 0.170 |
Why?
|
alpha-Amylases | 1 | 2019 | 39 | 0.170 |
Why?
|
Child | 11 | 2023 | 80089 | 0.170 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6403 | 0.160 |
Why?
|
Vaccination | 2 | 2022 | 3370 | 0.160 |
Why?
|
Prevalence | 10 | 2023 | 15702 | 0.160 |
Why?
|
Steroids | 1 | 2004 | 928 | 0.160 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2020 | 244 | 0.160 |
Why?
|
Dogs | 1 | 2024 | 3837 | 0.160 |
Why?
|
Animals | 15 | 2024 | 168202 | 0.160 |
Why?
|
Adolescent Behavior | 1 | 2007 | 1188 | 0.160 |
Why?
|
Intergenerational Relations | 1 | 2019 | 67 | 0.160 |
Why?
|
Nutritional Status | 1 | 2007 | 1597 | 0.160 |
Why?
|
Hypersensitivity | 1 | 2007 | 1167 | 0.150 |
Why?
|
Science | 1 | 2021 | 239 | 0.150 |
Why?
|
Alzheimer Disease | 4 | 2023 | 8603 | 0.150 |
Why?
|
Hip Fractures | 2 | 2022 | 988 | 0.150 |
Why?
|
Social Responsibility | 1 | 2021 | 385 | 0.150 |
Why?
|
Health Surveys | 6 | 2019 | 4036 | 0.150 |
Why?
|
Research Report | 1 | 2021 | 367 | 0.150 |
Why?
|
Isoenzymes | 1 | 2003 | 1687 | 0.150 |
Why?
|
A Kinase Anchor Proteins | 1 | 2018 | 57 | 0.150 |
Why?
|
Arylalkylamine N-Acetyltransferase | 1 | 2017 | 13 | 0.150 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2008 | 2916 | 0.150 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 517 | 0.150 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2019 | 557 | 0.140 |
Why?
|
Saliva | 2 | 2019 | 828 | 0.140 |
Why?
|
Students | 1 | 2007 | 1736 | 0.140 |
Why?
|
Carcinoma | 1 | 2008 | 2328 | 0.140 |
Why?
|
Cultural Diversity | 1 | 2021 | 369 | 0.140 |
Why?
|
Lung Neoplasms | 5 | 2020 | 13383 | 0.140 |
Why?
|
Pre-Eclampsia | 2 | 2023 | 1230 | 0.140 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2018 | 200 | 0.140 |
Why?
|
Dietary Supplements | 2 | 2024 | 3412 | 0.140 |
Why?
|
Nerve Tissue Proteins | 3 | 2017 | 4408 | 0.140 |
Why?
|
Renal Replacement Therapy | 1 | 2019 | 281 | 0.140 |
Why?
|
Preconception Care | 1 | 2018 | 141 | 0.140 |
Why?
|
Urothelium | 1 | 2018 | 269 | 0.140 |
Why?
|
Health Policy | 2 | 2021 | 2682 | 0.140 |
Why?
|
Epidemiologic Studies | 1 | 2020 | 673 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 7 | 2018 | 17878 | 0.140 |
Why?
|
Walking | 1 | 2024 | 1197 | 0.140 |
Why?
|
Anti-Mullerian Hormone | 1 | 2019 | 407 | 0.130 |
Why?
|
Biological Specimen Banks | 2 | 2021 | 778 | 0.130 |
Why?
|
Polymorphism, Single Nucleotide | 7 | 2021 | 15908 | 0.130 |
Why?
|
Population Surveillance | 3 | 2021 | 2597 | 0.130 |
Why?
|
Parturition | 1 | 2020 | 447 | 0.130 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 148 | 0.130 |
Why?
|
Mendelian Randomization Analysis | 1 | 2021 | 1007 | 0.130 |
Why?
|
Chronic Disease | 4 | 2023 | 9310 | 0.130 |
Why?
|
Erythrocytes | 2 | 1995 | 2410 | 0.130 |
Why?
|
Sleep Apnea, Obstructive | 2 | 2021 | 1877 | 0.130 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 730 | 0.130 |
Why?
|
Estrogens | 1 | 2002 | 1521 | 0.130 |
Why?
|
Quinine | 1 | 1995 | 51 | 0.130 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2010 | 4010 | 0.120 |
Why?
|
Interviews as Topic | 2 | 2015 | 2697 | 0.120 |
Why?
|
Blindness | 2 | 2009 | 585 | 0.120 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2016 | 302 | 0.120 |
Why?
|
Spinal Fractures | 1 | 2022 | 704 | 0.120 |
Why?
|
Environmental Exposure | 2 | 2022 | 4483 | 0.120 |
Why?
|
Lifting | 1 | 2015 | 55 | 0.120 |
Why?
|
Adenocarcinoma, Clear Cell | 1 | 2016 | 217 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2015 | 2092 | 0.120 |
Why?
|
Carcinogens, Environmental | 1 | 2015 | 72 | 0.120 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5144 | 0.120 |
Why?
|
Genotype | 6 | 2018 | 12977 | 0.120 |
Why?
|
Women's Health | 3 | 2020 | 2066 | 0.120 |
Why?
|
Chronotherapy | 3 | 2022 | 11 | 0.120 |
Why?
|
Creatine | 1 | 2016 | 427 | 0.120 |
Why?
|
Ovary | 1 | 2019 | 959 | 0.120 |
Why?
|
Interprofessional Relations | 1 | 2020 | 991 | 0.120 |
Why?
|
International Agencies | 1 | 2015 | 242 | 0.120 |
Why?
|
Age of Onset | 2 | 2019 | 3303 | 0.120 |
Why?
|
Drug Resistance, Multiple | 1 | 1995 | 255 | 0.110 |
Why?
|
Prostatic Neoplasms | 6 | 2017 | 11107 | 0.110 |
Why?
|
Interferon-alpha | 2 | 1995 | 901 | 0.110 |
Why?
|
Microsatellite Instability | 4 | 2012 | 716 | 0.110 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1743 | 0.110 |
Why?
|
Fertility | 2 | 2015 | 769 | 0.110 |
Why?
|
Benchmarking | 1 | 2020 | 1045 | 0.110 |
Why?
|
Self Report | 4 | 2022 | 3727 | 0.110 |
Why?
|
Socioeconomic Factors | 2 | 2019 | 7805 | 0.110 |
Why?
|
Linear Models | 5 | 2019 | 5866 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 785 | 0.110 |
Why?
|
Epidemiologic Methods | 3 | 2010 | 1335 | 0.110 |
Why?
|
Exercise | 3 | 2024 | 5886 | 0.110 |
Why?
|
Diet, Mediterranean | 1 | 2020 | 738 | 0.110 |
Why?
|
Epidemiologic Research Design | 1 | 2016 | 368 | 0.110 |
Why?
|
Weight Gain | 3 | 2024 | 2349 | 0.110 |
Why?
|
Schools | 1 | 2022 | 1483 | 0.110 |
Why?
|
Publications | 1 | 2015 | 194 | 0.100 |
Why?
|
Communicable Diseases | 1 | 2021 | 871 | 0.100 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1400 | 0.100 |
Why?
|
Public Health | 3 | 2021 | 2671 | 0.100 |
Why?
|
Body Weight | 2 | 2020 | 4615 | 0.100 |
Why?
|
Burnout, Professional | 1 | 2020 | 703 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2019 | 1141 | 0.100 |
Why?
|
Child, Preschool | 4 | 2024 | 42193 | 0.100 |
Why?
|
Calcium Channels, T-Type | 1 | 2011 | 28 | 0.100 |
Why?
|
Health Promotion | 1 | 2003 | 2206 | 0.100 |
Why?
|
Nursing Staff, Hospital | 1 | 2015 | 348 | 0.100 |
Why?
|
Nursing Staff | 1 | 2012 | 113 | 0.090 |
Why?
|
Polysomnography | 2 | 2016 | 1852 | 0.090 |
Why?
|
Spouses | 1 | 2014 | 283 | 0.090 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1995 | 678 | 0.090 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2011 | 57 | 0.090 |
Why?
|
Comorbidity | 6 | 2020 | 10507 | 0.090 |
Why?
|
Early Detection of Cancer | 2 | 2023 | 3196 | 0.090 |
Why?
|
Maternal Exposure | 1 | 2018 | 1067 | 0.090 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3798 | 0.090 |
Why?
|
Calcium Channel Blockers | 2 | 2010 | 694 | 0.090 |
Why?
|
Actigraphy | 1 | 2015 | 522 | 0.090 |
Why?
|
Adaptation, Psychological | 1 | 2021 | 2632 | 0.090 |
Why?
|
Receptors, Retinoic Acid | 1 | 2011 | 224 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2015 | 737 | 0.090 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 178 | 0.090 |
Why?
|
Hair Color | 1 | 2011 | 131 | 0.090 |
Why?
|
Dihydropyridines | 1 | 2010 | 67 | 0.090 |
Why?
|
Epidemiology | 1 | 2013 | 279 | 0.090 |
Why?
|
Family Health | 1 | 2015 | 1253 | 0.090 |
Why?
|
Amlodipine | 1 | 2010 | 84 | 0.090 |
Why?
|
Double-Blind Method | 3 | 2014 | 12333 | 0.080 |
Why?
|
Disease Progression | 4 | 2022 | 13495 | 0.080 |
Why?
|
Pathology, Molecular | 1 | 2013 | 329 | 0.080 |
Why?
|
Renal Dialysis | 1 | 2019 | 1795 | 0.080 |
Why?
|
Medical Records | 1 | 2015 | 1408 | 0.080 |
Why?
|
Radioimmunoassay | 1 | 2010 | 861 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 760 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2515 | 0.080 |
Why?
|
Workload | 1 | 2015 | 844 | 0.080 |
Why?
|
Sensitivity and Specificity | 3 | 2022 | 14649 | 0.080 |
Why?
|
Progesterone | 1 | 2013 | 742 | 0.080 |
Why?
|
Vitamin B 6 Deficiency | 1 | 2008 | 18 | 0.080 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6074 | 0.080 |
Why?
|
Aromatase | 1 | 2008 | 147 | 0.080 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 504 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2921 | 0.080 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2018 | 6016 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2011 | 697 | 0.080 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1748 | 0.070 |
Why?
|
Blood Cells | 1 | 2010 | 305 | 0.070 |
Why?
|
Research Design | 4 | 2011 | 6174 | 0.070 |
Why?
|
Climacteric | 1 | 2007 | 57 | 0.070 |
Why?
|
Caregivers | 2 | 2014 | 2241 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2020 | 20077 | 0.070 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 117 | 0.070 |
Why?
|
Colon | 2 | 2019 | 1791 | 0.070 |
Why?
|
Educational Status | 1 | 2015 | 2509 | 0.070 |
Why?
|
Predictive Value of Tests | 3 | 2017 | 15250 | 0.070 |
Why?
|
Sex Characteristics | 2 | 2020 | 2637 | 0.070 |
Why?
|
Tryptophan | 1 | 2009 | 482 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2021 | 12661 | 0.070 |
Why?
|
Electroencephalography | 1 | 2023 | 6240 | 0.070 |
Why?
|
Physical Fitness | 2 | 2016 | 743 | 0.070 |
Why?
|
Los Angeles | 1 | 2007 | 244 | 0.070 |
Why?
|
Epigenomics | 1 | 2013 | 942 | 0.070 |
Why?
|
Uric Acid | 1 | 2013 | 806 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2474 | 0.070 |
Why?
|
Education | 1 | 2009 | 534 | 0.070 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6807 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2252 | 0.070 |
Why?
|
Menarche | 1 | 2009 | 532 | 0.070 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2896 | 0.070 |
Why?
|
Chromatography, Liquid | 2 | 2020 | 982 | 0.070 |
Why?
|
Administration, Oral | 2 | 2012 | 4010 | 0.060 |
Why?
|
Health Status | 1 | 2019 | 4076 | 0.060 |
Why?
|
Time | 1 | 2007 | 545 | 0.060 |
Why?
|
Genes, p53 | 1 | 2008 | 712 | 0.060 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1551 | 0.060 |
Why?
|
Vitamins | 1 | 2014 | 1635 | 0.060 |
Why?
|
Dementia | 1 | 2020 | 2686 | 0.060 |
Why?
|
Social Support | 2 | 2006 | 2174 | 0.060 |
Why?
|
Cerebral Infarction | 1 | 2010 | 980 | 0.060 |
Why?
|
Receptors, Estrogen | 1 | 2013 | 2208 | 0.060 |
Why?
|
Life Change Events | 1 | 2010 | 953 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 942 | 0.060 |
Why?
|
Alleles | 2 | 2015 | 6861 | 0.060 |
Why?
|
Coronary Disease | 1 | 2019 | 5911 | 0.060 |
Why?
|
Androstenols | 1 | 2004 | 25 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 809 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2008 | 583 | 0.060 |
Why?
|
Sexual Harassment | 1 | 2005 | 82 | 0.060 |
Why?
|
Myocardial Infarction | 2 | 2016 | 11458 | 0.060 |
Why?
|
Osteoporosis | 1 | 2014 | 1604 | 0.060 |
Why?
|
Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2023 | 80583 | 0.060 |
Why?
|
Confidence Intervals | 2 | 2011 | 2925 | 0.060 |
Why?
|
Darkness | 1 | 2004 | 158 | 0.060 |
Why?
|
Psoriasis | 1 | 2012 | 944 | 0.060 |
Why?
|
Ulnar Nerve | 1 | 2004 | 102 | 0.060 |
Why?
|
Amitriptyline | 1 | 2004 | 112 | 0.060 |
Why?
|
Publication Bias | 1 | 2004 | 160 | 0.060 |
Why?
|
Serotonin | 1 | 2008 | 1041 | 0.060 |
Why?
|
Acetaminophen | 1 | 2008 | 555 | 0.060 |
Why?
|
Carcinogenicity Tests | 1 | 2023 | 38 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2020 | 4252 | 0.060 |
Why?
|
Iceland | 2 | 2014 | 184 | 0.060 |
Why?
|
Cattle | 1 | 2009 | 3841 | 0.060 |
Why?
|
Infant | 3 | 2022 | 36157 | 0.060 |
Why?
|
Biological Availability | 1 | 2004 | 389 | 0.050 |
Why?
|
Organoplatinum Compounds | 1 | 2005 | 407 | 0.050 |
Why?
|
Respiratory Sounds | 1 | 2007 | 702 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2734 | 0.050 |
Why?
|
Survivors | 1 | 2014 | 2373 | 0.050 |
Why?
|
Nutrition Surveys | 2 | 2021 | 1725 | 0.050 |
Why?
|
Immunohistochemistry | 3 | 2019 | 11069 | 0.050 |
Why?
|
Social Isolation | 1 | 2006 | 365 | 0.050 |
Why?
|
Nucleoproteins | 1 | 2023 | 113 | 0.050 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2003 | 767 | 0.050 |
Why?
|
Xenobiotics | 1 | 2022 | 70 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2019 | 64572 | 0.050 |
Why?
|
Survival Analysis | 4 | 2012 | 10072 | 0.050 |
Why?
|
Infant, Newborn | 2 | 2020 | 26183 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1750 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14024 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2009 | 2422 | 0.050 |
Why?
|
Skin Temperature | 1 | 2022 | 96 | 0.050 |
Why?
|
Secretory Rate | 1 | 2001 | 81 | 0.050 |
Why?
|
Prolactin | 1 | 2004 | 625 | 0.050 |
Why?
|
Carrier Proteins | 1 | 2015 | 4937 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2014 | 1921 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Neuropsychological Tests | 3 | 2023 | 7050 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 1 | 2008 | 1208 | 0.050 |
Why?
|
Blood Pressure | 3 | 2022 | 8473 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2010 | 4739 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1894 | 0.050 |
Why?
|
Seroepidemiologic Studies | 1 | 2023 | 398 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3149 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2008 | 2821 | 0.050 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 634 | 0.050 |
Why?
|
Insulin Resistance | 2 | 2013 | 3954 | 0.050 |
Why?
|
Prejudice | 1 | 2005 | 571 | 0.050 |
Why?
|
Visual Perception | 1 | 2009 | 1388 | 0.050 |
Why?
|
Smell | 1 | 2023 | 259 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2896 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 321 | 0.040 |
Why?
|
France | 1 | 2022 | 492 | 0.040 |
Why?
|
Body Temperature Regulation | 1 | 2022 | 292 | 0.040 |
Why?
|
Australia | 1 | 2024 | 1249 | 0.040 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 596 | 0.040 |
Why?
|
Lipid Metabolism | 1 | 2008 | 1896 | 0.040 |
Why?
|
Mass Vaccination | 1 | 2021 | 109 | 0.040 |
Why?
|
Genetic Variation | 1 | 2015 | 6561 | 0.040 |
Why?
|
Italy | 1 | 2022 | 842 | 0.040 |
Why?
|
Evidence-Based Medicine | 1 | 2012 | 3680 | 0.040 |
Why?
|
Cell Division | 2 | 2004 | 4457 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3776 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3447 | 0.040 |
Why?
|
Signal Transduction | 3 | 2019 | 23415 | 0.040 |
Why?
|
Specimen Handling | 1 | 2004 | 701 | 0.040 |
Why?
|
Stroke | 2 | 2014 | 9715 | 0.040 |
Why?
|
Pregnancy Trimester, First | 1 | 2023 | 908 | 0.040 |
Why?
|
Circadian Clocks | 1 | 2021 | 164 | 0.040 |
Why?
|
Thyroid Hormones | 1 | 2022 | 403 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2011 | 3607 | 0.040 |
Why?
|
Body Temperature | 1 | 2022 | 780 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9026 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2006 | 847 | 0.040 |
Why?
|
Food Contamination | 1 | 2020 | 191 | 0.040 |
Why?
|
Colonoscopy | 2 | 2023 | 1397 | 0.040 |
Why?
|
Intestinal Mucosa | 1 | 2010 | 3031 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 597 | 0.040 |
Why?
|
Mood Disorders | 1 | 2005 | 1127 | 0.040 |
Why?
|
Universities | 1 | 2003 | 994 | 0.040 |
Why?
|
Down-Regulation | 2 | 2016 | 2916 | 0.040 |
Why?
|
Drug Utilization | 1 | 2004 | 1186 | 0.040 |
Why?
|
Molecular Epidemiology | 1 | 2019 | 470 | 0.040 |
Why?
|
Nerve Block | 1 | 2004 | 705 | 0.040 |
Why?
|
Software Design | 1 | 2017 | 171 | 0.040 |
Why?
|
Autoimmune Diseases | 1 | 2009 | 2238 | 0.040 |
Why?
|
Zinc | 1 | 2021 | 687 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2019 | 331 | 0.040 |
Why?
|
Brazil | 1 | 2021 | 1229 | 0.040 |
Why?
|
Fetal Development | 1 | 2022 | 769 | 0.030 |
Why?
|
Patient Satisfaction | 1 | 2009 | 3451 | 0.030 |
Why?
|
Semantics | 1 | 2020 | 612 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5789 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2001 | 1700 | 0.030 |
Why?
|
BCG Vaccine | 1 | 2019 | 369 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 887 | 0.030 |
Why?
|
Independent Living | 1 | 2020 | 577 | 0.030 |
Why?
|
Metabolome | 1 | 2023 | 988 | 0.030 |
Why?
|
Genomic Instability | 2 | 2010 | 709 | 0.030 |
Why?
|
Drug Approval | 1 | 2003 | 812 | 0.030 |
Why?
|
Temperature | 1 | 2022 | 2224 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2005 | 2465 | 0.030 |
Why?
|
Information Systems | 1 | 2017 | 396 | 0.030 |
Why?
|
Data Collection | 1 | 2004 | 3316 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3245 | 0.030 |
Why?
|
Academies and Institutes | 1 | 2017 | 318 | 0.030 |
Why?
|
Epidemics | 1 | 2021 | 512 | 0.030 |
Why?
|
Metabolic Clearance Rate | 1 | 1995 | 361 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 891 | 0.030 |
Why?
|
Environment | 1 | 2021 | 1123 | 0.030 |
Why?
|
Models, Biological | 3 | 2021 | 9461 | 0.030 |
Why?
|
Verapamil | 1 | 1995 | 242 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1422 | 0.030 |
Why?
|
Regression Analysis | 3 | 2013 | 6339 | 0.030 |
Why?
|
Pituitary-Adrenal System | 1 | 2017 | 553 | 0.030 |
Why?
|
Eating | 1 | 2020 | 1535 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1186 | 0.030 |
Why?
|
Half-Life | 1 | 1995 | 650 | 0.030 |
Why?
|
Adiposity | 1 | 2024 | 1879 | 0.030 |
Why?
|
Drug Interactions | 2 | 1995 | 1415 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2019 | 1810 | 0.030 |
Why?
|
Urban Population | 1 | 2021 | 2034 | 0.030 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2017 | 702 | 0.030 |
Why?
|
Prescription Drugs | 2 | 2010 | 631 | 0.030 |
Why?
|
Pneumonia | 1 | 2024 | 2143 | 0.030 |
Why?
|
Depressive Disorder | 1 | 2005 | 3735 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2023 | 2756 | 0.030 |
Why?
|
Age Distribution | 2 | 2010 | 2872 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1454 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2020 | 2174 | 0.020 |
Why?
|
Prognosis | 5 | 2011 | 29601 | 0.020 |
Why?
|
Triglycerides | 1 | 2019 | 2459 | 0.020 |
Why?
|
Breast Feeding | 1 | 2020 | 1355 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 928 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3205 | 0.020 |
Why?
|
Organ Size | 1 | 2016 | 2252 | 0.020 |
Why?
|
Climate Change | 1 | 2017 | 500 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 3117 | 0.020 |
Why?
|
Lip Neoplasms | 1 | 2010 | 36 | 0.020 |
Why?
|
Phenotype | 1 | 2008 | 16572 | 0.020 |
Why?
|
Biological Transport | 1 | 2015 | 2089 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2022 | 4533 | 0.020 |
Why?
|
Rural Population | 1 | 2021 | 2277 | 0.020 |
Why?
|
Cholesterol | 1 | 2019 | 2902 | 0.020 |
Why?
|
Cholesterol, LDL | 1 | 2019 | 2378 | 0.020 |
Why?
|
Fluorouracil | 1 | 1995 | 1642 | 0.020 |
Why?
|
Quantitative Trait Loci | 1 | 2018 | 2112 | 0.020 |
Why?
|
Sulfites | 1 | 2010 | 83 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2005 | 11735 | 0.020 |
Why?
|
Survival Rate | 3 | 2012 | 12719 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3601 | 0.020 |
Why?
|
Community Health Planning | 1 | 2010 | 164 | 0.020 |
Why?
|
Mass Screening | 1 | 2005 | 5425 | 0.020 |
Why?
|
Mutation | 2 | 2011 | 30015 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2007 | 10754 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2021 | 3310 | 0.020 |
Why?
|
Medical History Taking | 1 | 2012 | 773 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 1995 | 2079 | 0.020 |
Why?
|
Substance-Related Disorders | 1 | 2005 | 4416 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 1995 | 6520 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3332 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8619 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3820 | 0.020 |
Why?
|
Disease Susceptibility | 2 | 2005 | 1788 | 0.020 |
Why?
|
Drug Administration Schedule | 2 | 2007 | 4845 | 0.020 |
Why?
|
Communication | 1 | 2021 | 3851 | 0.020 |
Why?
|
Chronobiology Phenomena | 1 | 2006 | 29 | 0.020 |
Why?
|
Sample Size | 1 | 2009 | 838 | 0.020 |
Why?
|
Causality | 1 | 2012 | 1241 | 0.020 |
Why?
|
Area Under Curve | 1 | 2010 | 1635 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2009 | 991 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2003 | 7847 | 0.020 |
Why?
|
Mental Status Schedule | 1 | 2006 | 315 | 0.020 |
Why?
|
Kidney | 1 | 2020 | 7044 | 0.020 |
Why?
|
Receptors, Somatomedin | 1 | 2004 | 57 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2011 | 1300 | 0.010 |
Why?
|
Community Networks | 1 | 2006 | 201 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2018 | 11118 | 0.010 |
Why?
|
Etoposide | 1 | 2005 | 634 | 0.010 |
Why?
|
ras Proteins | 1 | 2008 | 1054 | 0.010 |
Why?
|
Terminology as Topic | 1 | 2010 | 1528 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1742 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4569 | 0.010 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2016 | 3077 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3410 | 0.010 |
Why?
|
Erythema | 1 | 2004 | 262 | 0.010 |
Why?
|
Protein Binding | 1 | 1995 | 9345 | 0.010 |
Why?
|
Somatostatin | 1 | 2004 | 447 | 0.010 |
Why?
|
ROC Curve | 1 | 2010 | 3575 | 0.010 |
Why?
|
Outpatients | 1 | 2010 | 1596 | 0.010 |
Why?
|
Social Class | 1 | 2010 | 1993 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2005 | 888 | 0.010 |
Why?
|
Coffee | 1 | 2006 | 592 | 0.010 |
Why?
|
Bupivacaine | 1 | 2004 | 411 | 0.010 |
Why?
|
Autoantibodies | 1 | 2009 | 2115 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2008 | 1745 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 8542 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3593 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2358 | 0.010 |
Why?
|
Biomedical Research | 1 | 2015 | 3426 | 0.010 |
Why?
|
Clinical Trials as Topic | 2 | 2005 | 7995 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2689 | 0.010 |
Why?
|
Longevity | 1 | 2004 | 1064 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4512 | 0.010 |
Why?
|
Databases, Factual | 1 | 2010 | 7963 | 0.010 |
Why?
|
Homeostasis | 1 | 2004 | 3321 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2004 | 2878 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1995 | 2214 | 0.010 |
Why?
|
Brain | 1 | 2016 | 27100 | 0.010 |
Why?
|
Pain | 1 | 2004 | 5062 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36401 | 0.000 |
Why?
|
Drug Resistance | 1 | 1995 | 1594 | 0.000 |
Why?
|
Apoptosis | 1 | 2004 | 9476 | 0.000 |
Why?
|
Mice | 1 | 2004 | 81368 | 0.000 |
Why?
|